University of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2013

  1. Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells

    British Journal of Cancer, Vol. 108, Núm. 10, pp. 2005-2012

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

  2. Upsides and downsides of reactive oxygen species for Cancer: The roles of reactive oxygen species in tumorigenesis, prevention, and therapy

    Antioxidants and Redox Signaling, Vol. 16, Núm. 11, pp. 1295-1322

2010

  1. The RB-E2F1 Pathway Regulates Autophagy

    Cancer Research, Vol. 70, Núm. 20, pp. 7882-7893

  2. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype.

    Oncotarget, Vol. 1, Núm. 8, pp. 700-709

2009

  1. Encountering and advancing through antiangiogenesis therapy for gliomas

    Current Pharmaceutical Design, Vol. 15, Núm. 4, pp. 353-364

2008

  1. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

    Autophagy, Vol. 4, Núm. 2, pp. 151-175

  2. Tie2: A journey from normal angiogenesis to cancer and beyond

    Histology and Histopathology, Vol. 23, Núm. 6, pp. 773-780